Liquidia Corp. (LQDA)
64.00
+0.10
(+0.16%)
USD |
NASDAQ |
Jun 09, 16:00
64.47
+0.47
(+0.73%)
After-Hours: 20:00
Liquidia Research and Development Expense (Quarterly) : 12.27M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 9.00M |
| ANI Pharmaceuticals, Inc. | 10.60M |
| Corcept Therapeutics, Inc. | 66.26M |
| Viatris, Inc. | 245.20M |
| ADMA Biologics, Inc. | 2.597M |